These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
801 related articles for article (PubMed ID: 17999134)
21. Monitoring drug safety in Astrakhan, Russia. Kirilochev OO; Dorfman IP; Umerova AR Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700 [TBL] [Abstract][Full Text] [Related]
22. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Aagaard L; Weber CB; Hansen EH Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864 [TBL] [Abstract][Full Text] [Related]
23. [Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)]. Eckhardt K; Cremer-Schaeffer P; König J; Paeschke N Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):173-80. PubMed ID: 15726458 [TBL] [Abstract][Full Text] [Related]
24. Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia. Littlejohn ES; Clothier HJ; Perrett KP; Danchin M Hum Vaccin Immunother; 2015; 11(7):1828-35. PubMed ID: 26075435 [TBL] [Abstract][Full Text] [Related]
25. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean. Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798 [TBL] [Abstract][Full Text] [Related]
26. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy. Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462 [TBL] [Abstract][Full Text] [Related]
27. Annual report: surveillance of adverse events following immunisation in Australia, 2009. Mahajan D; Roomiani I; Gold MS; Lawrence GL; McIntyre PB; Menzies RI Commun Dis Intell Q Rep; 2010 Sep; 34(3):259-76. PubMed ID: 21090181 [TBL] [Abstract][Full Text] [Related]
28. An adverse drug event manager facilitates spontaneous reporting of adverse drug reactions. Vinther S; Klarskov P; Borgeskov H; Darsø P; Christophersen AK; Borck B; Christensen C; Hansen MV; Halladin NM; Christensen MB; Harboe KM; Lund M; Jimenez-Solem E Dan Med J; 2017 Jan; 64(1):. PubMed ID: 28007050 [TBL] [Abstract][Full Text] [Related]
29. Surveillance of adverse events following immunization: 10 years' experience in Oman. Al Awaidy S; Bawikar S; Prakash KR; Al Rawahi B; Mohammed AJ East Mediterr Health J; 2010 May; 16(5):474-80. PubMed ID: 20799545 [TBL] [Abstract][Full Text] [Related]
30. Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination system. Alguacil-Ramos AM; Muelas-Tirado J; Garrigues-Pelufo TM; Portero-Alonso A; Diez-Domingo J; Pastor-Villalba E; Lluch-Rodrigo JA Public Health; 2016 Jun; 135():66-74. PubMed ID: 26976484 [TBL] [Abstract][Full Text] [Related]
31. Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system. Tiaden JD; Wenzel E; Berthold HK; Müller-Oerlinghausen B Semin Thromb Hemost; 2005; 31(4):371-80. PubMed ID: 16149013 [TBL] [Abstract][Full Text] [Related]
32. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Kimland E; Rane A; Ufer M; Panagiotidis G Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):493-9. PubMed ID: 15918163 [TBL] [Abstract][Full Text] [Related]
33. The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme. Ranganathan SS; Houghton JE; Davies DP; Routledge PA Br J Clin Pharmacol; 2003 Dec; 56(6):658-63. PubMed ID: 14616426 [TBL] [Abstract][Full Text] [Related]
34. Causality assessment of serious and severe adverse events following immunization in India: a 4-year practical experience. Singh AK; Wagner AL; Joshi J; Carlson BF; Aneja S; Boulton ML Expert Rev Vaccines; 2018 Jun; 17(6):555-562. PubMed ID: 29865876 [TBL] [Abstract][Full Text] [Related]
35. Surveillance of suspected adverse reactions to natural health products in Italy. Menniti-Ippolito F; Mazzanti G; Santuccio C; Moro PA; Calapai G; Firenzuoli F; Valeri A; Raschetti R Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):626-35. PubMed ID: 18327867 [TBL] [Abstract][Full Text] [Related]
36. Simultaneous vaccination of Chinese applicants for a United States immigrant visa. Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068 [TBL] [Abstract][Full Text] [Related]
37. Patient Reporting in the EU: Analysis of EudraVigilance Data. Banovac M; Candore G; Slattery J; Houÿez F; Haerry D; Genov G; Arlett P Drug Saf; 2017 Jul; 40(7):629-645. PubMed ID: 28417320 [TBL] [Abstract][Full Text] [Related]
38. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013. Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA; MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673 [TBL] [Abstract][Full Text] [Related]
39. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China. Guo B; Page A; Wang H; Taylor R; McIntyre P Vaccine; 2013 Jan; 31(4):603-17. PubMed ID: 23200940 [TBL] [Abstract][Full Text] [Related]